Professor Sam Kinyanjui
- Head of Training and Capacity Building
Professor Sam Kinyanjui is the Head of Training and Capacity Building at the KEMRI-Wellcome Trust Programme in Kenya and the Director for the Initiative to Develop African Research Leaders (IDeAL). Prior to current position he pent 16 years doing research on the immunology and molecular biology of malaria parasites. During this period he developed a strong interest in capacity building for health research in Africa.
As the Head of Training and Capacity Building at the KWTRP in Kenya he provides scientific, and strategic guidance for academic training towards research leadership. His key achievement has been the development and implementation of a comprehensive research career framework for attracting, training and retaining African research leaders. Through the framework Professor Kinyanjui has overseen the training of over 200 graduate interns, the majority of who have taken up a research career after the internship. This scheme has now been developed into a nationally accredited Postgraduate Diploma in Health Research Methods. He has also overseen over 100 Masters and over 70 PhD training since 2008. In 2015 Professor Kinyanjui was awarded a further 8 million pounds by the Wellcome Trust/DIFD to build on this work through the Initiative to Develop African Research Leaders (IDeAL)
Regionally, Professor Kinyanjui is involved in advocacy for increased commitment to building research capacity in Africa by both African governments and funding agencies. In 2006 he worked at the African Union Headquarter promoting health research agenda within the Union. He also sits on the advisory boards of several African capacity building initiatives including MUIIplus, SSACAB, SANTHE and the TDR Global Community Adhoc Workgroup.
The burden of neurological impairments and disability in older children measured in disability-adjusted life-years in rural Kenya
Abuga JA. et al, (2022), PLOS Global Public Health, 2
Comparing drug regimens for clearance of malaria parasites in asymptomatic adults using PCR in Kilifi County, Kenya: an open-label randomised controlled clinical trial (MalPaC)
Khaemba EN. et al, (2020), Wellcome Open Research, 5, 36 - 36
IgM in human immunity to Plasmodium falciparum malaria.
Boyle MJ. et al, (2019), Science advances, 5
Enhancing quality and integrity in biomedical research in Africa: an international call for greater focus, investment and standardisation in capacity strengthening for frontline staff
Kombe F., (2015), BMC Medical Ethics, 16
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria
Murungi LM. et al, (2013), Vaccine, 31, 3936 - 3942